Intramyocardial adenoviral vascular endothelial growth factor-D ∆N∆C gene therapy does not induce ventricular arrhythmias.
Aleksi J LeikasIiro HassinenAntti KiveläAntti HedmanHanna MussaloSuo Ctc Bladder CommitteeJuha E K HartikainenPublished in: The journal of gene medicine (2022)
In conclusion, our results suggest that AdVEGF-D GT does not predispose to arrhythmias and might improve HRV metrics.